{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:04Z","timestamp":1791655384214,"version":"4.3.4"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41585-023-00838-8","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:02:29Z","timestamp":1704276149000},"page":"303-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The effect of red blood cell disorders on male fertility and reproductive health"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9268-3413","authenticated-orcid":false,"given":"Bryan D.","family":"Naelitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajit S.","family":"Khooblall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel V.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8282-2339","authenticated-orcid":false,"given":"Sarah C.","family":"Vij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Rotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0127-4295","authenticated-orcid":false,"given":"Scott D.","family":"Lundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"838_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","volume":"108","author":"F Zegers-Hochschild","year":"2017","unstructured":"Zegers-Hochschild, F. et al. The international glossary on infertility and fertility care, 2017. Fertil. Steril. 108, 393\u2013406 (2017).","journal-title":"Fertil. Steril."},{"key":"838_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(20)32667-2","volume":"397","author":"A Agarwal","year":"2021","unstructured":"Agarwal, A. et al. Male infertility. Lancet 397, 319\u2013333 (2021).","journal-title":"Lancet"},{"key":"838_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12958-015-0032-1","volume":"13","author":"A Agarwal","year":"2015","unstructured":"Agarwal, A., Mulgund, A., Hamada, A. & Chyatte, M. R. A unique view on male infertility around the globe. Reprod. Biol. Endocrinol. 13, 37 (2015).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"838_CR4","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.fertnstert.2014.12.103","volume":"103","author":"Practice Committee of the American Society for Reproductive Medicine.","year":"2015","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertil. Steril. 103, e18\u2013e25 (2015).","journal-title":"Fertil. Steril."},{"key":"838_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/bmj.305.6854.609","volume":"305","author":"E Carlsen","year":"1992","unstructured":"Carlsen, E., Giwercman, A., Keiding, N. & Skakkebaek, N. E. Evidence for decreasing quality of semen during past 50 years. BMJ 305, 609\u2013613 (1992).","journal-title":"BMJ"},{"key":"838_CR6","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.envint.2018.10.052","volume":"121","author":"L M\u00ednguez-Alarc\u00f3n","year":"2018","unstructured":"M\u00ednguez-Alarc\u00f3n, L. et al. Secular trends in semen parameters among men attending a fertility center between 2000 and 2017: identifying potential predictors. Environ. Int. 121, 1297\u20131303 (2018).","journal-title":"Environ. Int."},{"key":"838_CR7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/1557988316643383","volume":"11","author":"P Sengupta","year":"2017","unstructured":"Sengupta, P., Dutta, S. & Krajewska-Kulak, E. The disappearing sperms: analysis of reports published between 1980 and 2015. Am. J. Mens. Health 11, 1279\u20131304 (2017).","journal-title":"Am. J. Mens. Health"},{"key":"838_CR8","first-page":"164","volume":"19","author":"N Abbaspour","year":"2014","unstructured":"Abbaspour, N., Hurrell, R. & Kelishadi, R. Review on iron and its importance for human health. J. Res. Med. Sci. 19, 164\u2013174 (2014).","journal-title":"J. Res. Med. Sci."},{"key":"838_CR9","doi-asserted-by":"publisher","first-page":"G397","DOI":"10.1152\/ajpgi.00348.2013","volume":"307","author":"S Gulek","year":"2014","unstructured":"Gulek, S., Anderson, G. J. & Collins, J. F. Mechanistic and regulatory aspects of intestinal iron absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G397\u2013G409 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"838_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fphar.2016.00160","volume":"7","author":"G Sebastiani","year":"2016","unstructured":"Sebastiani, G., Wilkinson, N. & Pantopoulos, K. Pharmacological targeting of the hepcidin\/ferroportin axis. Front. Pharmacol. 7, 160 (2016).","journal-title":"Front. Pharmacol."},{"key":"838_CR11","doi-asserted-by":"crossref","unstructured":"Ginzburg, Y. Z. Chapter two - hepcidin-ferroportin axis in health and disease. in: Litwack, G. (ed.) Vitamins and Hormones. 110, 17\u201345 (Academic Press, 2019).","DOI":"10.1016\/bs.vh.2019.01.002"},{"key":"838_CR12","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1159\/000243791","volume":"122","author":"E Nemeth","year":"2009","unstructured":"Nemeth, E. & Ganz, T. The role of hepcidin in iron metabolism. Acta Haematol. 122, 2284\u20132288 (2009).","journal-title":"Acta Haematol."},{"key":"838_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000210016","volume":"1","author":"L Wang","year":"2009","unstructured":"Wang, L. & Cherayil, B. J. Ironing out the wrinkles in host defense: interactions between iron homeostasis and innate immunity. J. Innate Immun. 1, 455\u2013464 (2009).","journal-title":"J. Innate Immun."},{"key":"838_CR14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4331\/wjbc.v5.i2.204","volume":"5","author":"G Musci","year":"2014","unstructured":"Musci, G., Polticelli, F. & Bonaccorsi di Patti, M. C. Ceruloplasmin-ferroportin system of iron traffic in vertebrates. World J. Biol. Chem. 5, 204\u2013215 (2014).","journal-title":"World J. Biol. Chem."},{"key":"838_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10534-012-9520-3","volume":"25","author":"TB Bartnikas","year":"2012","unstructured":"Bartnikas, T. B. Known and potential roles of transferrin in iron biology. Biometals 25, 677\u2013686 (2012).","journal-title":"Biometals"},{"key":"838_CR16","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1271\/bbb.64.1775","volume":"64","author":"R Sasaki","year":"2000","unstructured":"Sasaki, R., Masuda, S. & Nagao, M. Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci. Biotechnol. Biochem. 64, 1775\u20131793 (2000).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"838_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/humupd\/dmn004","volume":"14","author":"K Tremellen","year":"2008","unstructured":"Tremellen, K. Oxidative stress and male infertility\u2013a clinical perspective. Hum. Reprod. Update 14, 243\u2013258 (2008).","journal-title":"Hum. Reprod. Update"},{"key":"838_CR18","unstructured":"Farid, Y., Bowman, N. S. & Lecat, P. Biochemistry, hemoglobin synthesis. In: StatPearls. (StatPearls Publishing, 2022)."},{"key":"838_CR19","unstructured":"Harewood, J. & Azevedo, A. M. Alpha thalassemia. In: StatPearls. (StatPearls Publishing, 2022)."},{"key":"838_CR20","doi-asserted-by":"publisher","first-page":"a011684","DOI":"10.1101\/cshperspect.a011684","volume":"3","author":"BG Forget","year":"2013","unstructured":"Forget, B. G. & Bunn, H. F. Classification of the disorders of hemoglobin. Cold Spring Harb. Perspect. Med. 3, a011684 (2013).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"838_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1053\/j.semperi.2015.03.008","volume":"39","author":"BL Therrell","year":"2015","unstructured":"Therrell, B. L., Lloyd-Puryear, M. A., Eckman, J. R. & Mann, M. Y. Newborn screening for sickle cell diseases in the United States: a review of data spanning 2 decades. Semin. Perinatol. 39, 238\u2013251 (2015).","journal-title":"Semin. Perinatol."},{"key":"838_CR22","unstructured":"Sedrak A & Kondamudi NP. Sickle Cell Disease. (StatPearls Publishing, 2022)."},{"key":"838_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd, P., Gladwin, M. T. & Novelli, E. M. Pathophysiology of sickle cell disease. Annu. Rev. Pathol. 14, 263\u2013292 (2019).","journal-title":"Annu. Rev. Pathol."},{"key":"838_CR24","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees, D. C., Williams, T. N. & Gladwin, M. T. Sickle-cell disease. Lancet 376, 2018\u20132031 (2010).","journal-title":"Lancet"},{"key":"838_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01757-w","volume":"16","author":"N Yasara","year":"2021","unstructured":"Yasara, N., Premawardhena, A. & Mettananda, S. A comprehensive review of hydroxyurea for \u03b2-haemoglobinopathies: the role revisited during COVID-19 pandemic. Orphanet J. Rare Dis. 16, 114 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"838_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000337344","volume":"128","author":"A Taddesse","year":"2012","unstructured":"Taddesse, A. et al. Hypogonadism in patients with sickle cell disease: central or peripheral? Acta Haematol. 128, 65\u201368 (2012).","journal-title":"Acta Haematol."},{"key":"838_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1572","volume":"27","author":"W Fageera","year":"2018","unstructured":"Fageera, W. et al. Placebo response and its determinants in children with ADHD across multiple observers and settings: a randomized clinical trial. Int. J. Methods Psychiatr. Res. 27, e1572 (2018).","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"838_CR28","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1182\/blood-2014-07-577619","volume":"124","author":"K Smith-Whitley","year":"2014","unstructured":"Smith-Whitley, K. Reproductive issues in sickle cell disease. Blood 124, 3538\u20133543 (2014).","journal-title":"Blood"},{"key":"838_CR29","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3324\/haematol.11515","volume":"93","author":"I Berthaut","year":"2008","unstructured":"Berthaut, I. et al. Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Haematologica 93, 988\u2013993 (2008).","journal-title":"Haematologica"},{"key":"838_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1439-0272.1980.tb01347.x","volume":"12","author":"CR Nahoum","year":"1980","unstructured":"Nahoum, C. R., Fontes, E. A. & Freire, F. R. Semen analysis in sickle cell disease. Andrologia 12, 542\u2013545 (1980).","journal-title":"Andrologia"},{"key":"838_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1006\/taap.1998.8593","volume":"155","author":"J-H Shin","year":"1999","unstructured":"Shin, J.-H., Mori, C. & Shiota, K. Involvement of germ cell apoptosis in the induction of testicular toxicity following hydroxyurea treatment. Toxicol. Appl. Pharmacol. 155, 139\u2013149 (1999).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"838_CR32","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/ijerph6031124","volume":"6","author":"KM Jones","year":"2009","unstructured":"Jones, K. M. et al. Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints. Int. J. Environ. Res. Public. Health 6, 1124\u20131144 (2009).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"838_CR33","first-page":"22","volume":"65","author":"LK Sahoo","year":"2017","unstructured":"Sahoo, L. K. et al. Study of seminal fluid parameters and fertility of male sickle cell disease patients and potential impact of hydroxyurea treatment. J. Assoc. Physicians India 65, 22\u201325 (2017).","journal-title":"J. Assoc. Physicians India"},{"key":"838_CR34","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood-2017-03-771857","volume":"130","author":"B Isabelle","year":"2017","unstructured":"Isabelle, B. et al. Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment. Blood 130, 2354\u20132356 (2017).","journal-title":"Blood"},{"key":"838_CR35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood.2020006270","volume":"137","author":"L Joseph","year":"2021","unstructured":"Joseph, L. et al. Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease. Blood 137, 826\u2013829 (2021).","journal-title":"Blood"},{"key":"838_CR36","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood.2020008146","volume":"137","author":"G As","year":"2021","unstructured":"As, G. et al. Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease. Blood 137, 856\u2013859 (2021).","journal-title":"Blood"},{"key":"838_CR37","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1182\/bloodadvances.2017007708","volume":"1","author":"CD Fitzhugh","year":"2017","unstructured":"Fitzhugh, C. D. & Walters, M. C. The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia. Blood Adv. 1, 2563\u20132567 (2017).","journal-title":"Blood Adv."},{"key":"838_CR38","doi-asserted-by":"publisher","first-page":"969429","DOI":"10.3389\/fonc.2022.969429","volume":"12","author":"S Sargur Madabushi","year":"2022","unstructured":"Sargur Madabushi, S. et al. Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell disease. Front. Oncol. 12, 969429 (2022).","journal-title":"Front. Oncol."},{"key":"838_CR39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/bmt.2014.84","volume":"49","author":"M Bhatia","year":"2014","unstructured":"Bhatia, M. et al. Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transpl. 49, 913\u2013920 (2014).","journal-title":"Bone Marrow Transpl."},{"key":"838_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13496","volume":"23","author":"J Zhao","year":"2019","unstructured":"Zhao, J. et al. Adolescent male fertility following reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in non-malignant disorders. Pediatr. Transplant. 23, e13496 (2019).","journal-title":"Pediatr. Transplant."},{"key":"838_CR41","doi-asserted-by":"publisher","unstructured":"Can, B. et al. Gonadal status and sexual function at long-term follow-up after allogeneic stem cell transplantation in adult patients with sickle cell disease. Exp. Clin. Transplant. https:\/\/doi.org\/10.6002\/ect.2021.0392 (2022).","DOI":"10.6002\/ect.2021.0392"},{"key":"838_CR42","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1182\/blood.2019003776","volume":"138","author":"AA Abraham","year":"2021","unstructured":"Abraham, A. A. & Tisdale, J. F. Gene therapy for sickle cell disease: moving from the bench to the bedside. Blood 138, 932\u2013941 (2021).","journal-title":"Blood"},{"key":"838_CR43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2117175","volume":"386","author":"J Kanter","year":"2022","unstructured":"Kanter, J. et al. Biologic and clinical efficacy of lentiglobin for sickle cell disease. N. Engl. J. Med. 386, 617\u2013628 (2022).","journal-title":"N. Engl. J. Med."},{"key":"838_CR44","doi-asserted-by":"publisher","first-page":"892184","DOI":"10.3389\/fendo.2022.892184","volume":"13","author":"B Musicki","year":"2022","unstructured":"Musicki, B. & Burnett, A. L. Testosterone deficiency in sickle cell disease: recognition and remediation. Front. Endocrinol. 13, 892184 (2022).","journal-title":"Front. Endocrinol."},{"key":"838_CR45","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1210\/jc.2003-031719","volume":"89","author":"AB Araujo","year":"2004","unstructured":"Araujo, A. B. et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 89, 5920\u20135926 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"838_CR46","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/antiox10111834","volume":"10","author":"K Leisegang","year":"2021","unstructured":"Leisegang, K., Roychoudhury, S., Slama, P. & Finelli, R. The mechanisms and management of age-related oxidative stress in male hypogonadism associated with non-communicable chronic disease. Antioxid. Basel Switz. 10, 1834 (2021).","journal-title":"Antioxid. Basel Switz."},{"key":"838_CR47","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/antiox10060837","volume":"10","author":"S Roychoudhury","year":"2021","unstructured":"Roychoudhury, S. et al. Environmental factors-induced oxidative stress: hormonal and molecular pathway disruptions in hypogonadism and erectile dysfunction. Antioxidants 10, 837 (2021).","journal-title":"Antioxidants"},{"key":"838_CR48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/antiox10020296","volume":"10","author":"R Vona","year":"2021","unstructured":"Vona, R. et al. Sickle cell disease: role of oxidative stress and antioxidant therapy. Antioxid. Basel Switz. 10, 296 (2021).","journal-title":"Antioxid. Basel Switz."},{"key":"838_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/1756287214542096","volume":"6","author":"HR Levey","year":"2014","unstructured":"Levey, H. R., Segal, R. L. & Bivalacqua, T. J. Management of priapism: an update for clinicians. Ther. Adv. Urol. 6, 230\u2013244 (2014).","journal-title":"Ther. Adv. Urol."},{"key":"838_CR50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/andr.12442","volume":"6","author":"B Musicki","year":"2018","unstructured":"Musicki, B. et al. Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis. Andrology 6, 184\u2013191 (2018).","journal-title":"Andrology"},{"key":"838_CR51","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","volume":"189","author":"G Lagoda","year":"2013","unstructured":"Lagoda, G., Sezen, S. F., Cabrini, M. R., Musicki, B. & Burnett, A. L. Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis. J. Urol. 189, 762\u2013768 (2013).","journal-title":"J. Urol."},{"key":"838_CR52","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ucl.2005.08.007","volume":"32","author":"RC Dean","year":"2005","unstructured":"Dean, R. C. & Lue, T. F. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol. Clin. North. Am. 32, 379\u2013395 (2005).","journal-title":"Urol. Clin. North. Am."},{"key":"838_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","volume":"14","author":"C-S Lin","year":"2002","unstructured":"Lin, C.-S., Chow, S., Lau, A., Tu, R. & Lue, T. F. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. Int. J. Impot. Res. 14, 15\u201324 (2002).","journal-title":"Int. J. Impot. Res."},{"key":"838_CR54","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/molehr\/gaq049","volume":"16","author":"L Goglia","year":"2010","unstructured":"Goglia, L. et al. Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo. Mol. Hum. Reprod. 16, 761\u2013769 (2010).","journal-title":"Mol. Hum. Reprod."},{"key":"838_CR55","doi-asserted-by":"publisher","first-page":"297364","DOI":"10.1155\/2011\/297364","volume":"2011","author":"GM Crane","year":"2011","unstructured":"Crane, G. M. & Bennett, N. E. Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies. Anemia 2011, 297364 (2011).","journal-title":"Anemia"},{"key":"838_CR56","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/JU.0000000000001365","volume":"205","author":"LT Hou","year":"2021","unstructured":"Hou, L. T. & Burnett, A. L. Regimented phosphodiesterase type 5 inhibitor use reduces emergency department visits for recurrent ischemic priapism. J. Urol. 205, 545\u2013553 (2021).","journal-title":"J. Urol."},{"key":"838_CR57","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3390\/jcm11092318","volume":"11","author":"RS Nickel","year":"2022","unstructured":"Nickel, R. S. et al. Fertility after curative therapy for sickle cell disease: a comprehensive review to guide care. J. Clin. Med. 11, 2318 (2022).","journal-title":"J. Clin. Med."},{"key":"838_CR58","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1097\/AOG.0000000000001952","volume":"129","author":"Committee Opinion No. 691.","year":"2017","unstructured":"Committee Opinion No. 691. Carrier screening for genetic conditions. Obstet. Gynecol. 129, e41\u2013e55 (2017).","journal-title":"Obstet. Gynecol."},{"key":"838_CR59","doi-asserted-by":"publisher","first-page":"E1519","DOI":"10.1152\/ajpendo.00007.2012","volume":"302","author":"Y Leichtmann-Bardoogo","year":"2012","unstructured":"Leichtmann-Bardoogo, Y. et al. Compartmentalization and regulation of iron metabolism proteins protect male germ cells from iron overload. Am. J. Physiol. Endocrinol. Metab. 302, E1519\u2013E1530 (2012).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"838_CR60","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1182\/blood-2002-04-1182","volume":"100","author":"N Jabado","year":"2002","unstructured":"Jabado, N., Canonne-Hergaux, F., Gruenheid, S., Picard, V. & Gros, P. Iron transporter Nramp2\/DMT-1 is associated with the membrane of phagosomes in macrophages and Sertoli cells. Blood 100, 2617\u20132622 (2002).","journal-title":"Blood"},{"key":"838_CR61","doi-asserted-by":"publisher","first-page":"114344","DOI":"10.1016\/j.ecoenv.2022.114344","volume":"248","author":"F-L Zhang","year":"2022","unstructured":"Zhang, F.-L. et al. Multi-omics analysis reveals that iron deficiency impairs spermatogenesis by gut-hormone synthesis axis. Ecotoxicol. Environ. Saf. 248, 114344 (2022).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"838_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/abbi.1999.1476","volume":"372","author":"F Lucesoli","year":"1999","unstructured":"Lucesoli, F., Caligiuri, M., Roberti, M. F., Perazzo, J. C. & Fraga, C. G. Dose-dependent increase of oxidative damage in the testes of rats subjected to acute iron overload. Arch. Biochem. Biophys. 372, 37\u201343 (1999).","journal-title":"Arch. Biochem. Biophys."},{"key":"838_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijns5010016","volume":"5","author":"M Angastiniotis","year":"2019","unstructured":"Angastiniotis, M. & Lobitz, S. Thalassemias: an overview. Int. J. Neonatal Screen. 5, 16 (2019).","journal-title":"Int. J. Neonatal Screen."},{"key":"838_CR64","doi-asserted-by":"publisher","unstructured":"Bellis, G. & Parant, A. Beta-thalassemia in Mediterranean countries. Findings and outlook. Investig. Geogr\u00e1ficas https:\/\/doi.org\/10.14198\/INGEO.19079 (2021).","DOI":"10.14198\/INGEO.19079"},{"key":"838_CR65","unstructured":"Bajwa, H. & Basit, H. Thalassemia. in: StatPearls. (StatPearls Publishing, 2022)."},{"key":"838_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1788","volume":"9","author":"S Ali","year":"2021","unstructured":"Ali, S. et al. Current status of beta-thalassemia and its treatment strategies. Mol. Genet. Genom. Med. 9, e1788 (2021).","journal-title":"Mol. Genet. Genom. Med."},{"key":"838_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.hoc.2017.11.006","volume":"32","author":"V Viprakasit","year":"2018","unstructured":"Viprakasit, V. & Ekwattanakit, S. Clinical classification, screening and diagnosis for thalassemia. Hematol. Oncol. Clin. North. Am. 32, 193\u2013211 (2018).","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"838_CR68","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1111\/trf.16640","volume":"61","author":"A Lal","year":"2021","unstructured":"Lal, A. et al. The transfusion management of beta thalassemia in the United States. Transfusion 61, 3027\u20133039 (2021).","journal-title":"Transfusion"},{"key":"838_CR69","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","volume":"2017","author":"AT Taher","year":"2017","unstructured":"Taher, A. T. & Saliba, A. N. Iron overload in thalassemia: different organs at different rates. Hematol. Am. Soc. Hematol. Educ. Program. 2017, 265\u2013271 (2017).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"838_CR70","first-page":"6","volume":"89","author":"V De Sanctis","year":"2018","unstructured":"De Sanctis, V. et al. Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment. Acta Bio-Med. Atenei Parm. 89, 6\u201315 (2018).","journal-title":"Acta Bio-Med. Atenei Parm."},{"key":"838_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1986.1","volume":"53","author":"J Stewart","year":"1986","unstructured":"Stewart, J., Evan, G., Watson, J. & Sikora, K. Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br. J. Cancer 53, 1\u20136 (1986).","journal-title":"Br. J. Cancer"},{"key":"838_CR72","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/17474086.2017.1398080","volume":"10","author":"V De Sanctis","year":"2017","unstructured":"De Sanctis, V. et al. Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemia. Expert. Rev. Hematol. 10, 1095\u20131106 (2017).","journal-title":"Expert. Rev. Hematol."},{"key":"838_CR73","first-page":"271","volume":"8","author":"N Skordis","year":"2011","unstructured":"Skordis, N. & Kyriakou, A. The multifactorial origin of growth failure in thalassaemia. Pediatr. Endocrinol. Rev. PER 8, 271\u2013277 (2011).","journal-title":"Pediatr. Endocrinol. Rev. PER"},{"key":"838_CR74","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.juro.2008.01.103","volume":"179","author":"MR Safarinejad","year":"2008","unstructured":"Safarinejad, M. R. Evaluation of semen quality, endocrine profile and hypothalamus-pituitary-testis axis in male patients with homozygous \u03b2-thalassemia major. J. Urol. 179, 2327\u20132332 (2008).","journal-title":"J. Urol."},{"key":"838_CR75","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.fertnstert.2012.05.047","volume":"98","author":"A Soliman","year":"2012","unstructured":"Soliman, A., Yasin, M., El-Awwa, A., Osman, M. & de Sanctis, V. Acute effects of blood transfusion on pituitary gonadal axis and sperm parameters in adolescents and young men with thalassemia major: a pilot study. Fertil. Steril. 98, 638\u2013643 (2012).","journal-title":"Fertil. Steril."},{"key":"838_CR76","doi-asserted-by":"publisher","first-page":"E190","DOI":"10.1002\/ajh.24083","volume":"90","author":"ST Singer","year":"2015","unstructured":"Singer, S. T. et al. Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis. Am. J. Hematol. 90, E190\u2013E192 (2015).","journal-title":"Am. J. Hematol."},{"key":"838_CR77","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/humrep\/17.7.1820","volume":"17","author":"D Perera","year":"2002","unstructured":"Perera, D. et al. Sperm DNA damage in potentially fertile homozygous \u03b2-thalassaemia patients with iron overload. Hum. Reprod. 17, 1820\u20131825 (2002).","journal-title":"Hum. Reprod."},{"key":"838_CR78","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/pr.2017.296","volume":"83","author":"M-J Chen","year":"2018","unstructured":"Chen, M.-J. et al. Effect of iron overload on impaired fertility in male patients with transfusion-dependent beta-thalassemia. Pediatr. Res. 83, 655\u2013661 (2018).","journal-title":"Pediatr. Res."},{"key":"838_CR79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7123\/01.EJH.0000434285.33634.83","volume":"38","author":"M ElAlfy","year":"2013","unstructured":"ElAlfy, M. & Ragab, E. Alpha thalassemia: practice essentials, pathophysiology, etiology. Egypt. J. Haematol. 38, 149\u2013154 (2013).","journal-title":"Egypt. J. Haematol."},{"key":"838_CR80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0609.2004.00371.x","volume":"74","author":"S Shalitin","year":"2005","unstructured":"Shalitin, S. et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur. J. Haematol. 74, 93\u2013100 (2005).","journal-title":"Eur. J. Haematol."},{"key":"838_CR81","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.1995.tb02683.x","volume":"42","author":"Multicentre study on prevalence of endocrine complications in thalassaemia major.","year":"1995","unstructured":"Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian working group on endocrine complications in non-endocrine diseases. Clin. Endocrinol. 42, 581\u2013586 (1995).","journal-title":"Clin. Endocrinol."},{"key":"838_CR82","doi-asserted-by":"crossref","unstructured":"ElAlfy, M., Ragab, E., Abdel-Aziz, E., Massoud, W. & Elsedfy, H. Deferiprone and desferrioxamine combined chelation could improve puberty of adolescent males with \u03b2-thalassemia major with preserved pituitary and testicular function. Egypt. J. Haematol. 38, 149.","DOI":"10.7123\/01.EJH.0000434285.33634.83"},{"key":"838_CR83","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJM199009133231104","volume":"323","author":"N Bronspiegel-Weintrob","year":"1990","unstructured":"Bronspiegel-Weintrob, N. et al. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major. N. Engl. J. Med. 323, 713\u2013719 (1990).","journal-title":"N. Engl. J. Med."},{"key":"838_CR84","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13312-023-2865-1","volume":"60","author":"Y Arya","year":"2023","unstructured":"Arya, Y. & Sahi, P. K. Cell-based gene therapy for b-thalassemia. Indian. Pediatr. 60, 313\u2013316 (2023).","journal-title":"Indian. Pediatr."},{"key":"838_CR85","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","volume":"378","author":"AA Thompson","year":"2018","unstructured":"Thompson, A. A. et al. Gene therapy in patients with transfusion-dependent \u03b2-thalassemia. N. Engl. J. Med. 378, 1479\u20131493 (2018).","journal-title":"N. Engl. J. Med."},{"key":"838_CR86","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo, M. et al. Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia. Nature 467, 318\u2013322 (2010).","journal-title":"Nature"},{"key":"838_CR87","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1056\/NEJMoa2211644","volume":"388","author":"SW Pipe","year":"2023","unstructured":"Pipe, S. W. et al. Gene therapy with etranacogene dezaparvovec for hemophilia B. N. Engl. J. Med. 388, 706\u2013718 (2023).","journal-title":"N. Engl. J. Med."},{"key":"838_CR88","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/andr.13388","volume":"11","author":"M Huijben","year":"2023","unstructured":"Huijben, M. et al. Clomiphene citrate for male infertility: a systematic review and meta-analysis. Andrology 11, 987\u2013996 (2023).","journal-title":"Andrology"},{"key":"838_CR89","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.fertnstert.2023.06.032","volume":"120","author":"BD Naelitz","year":"2023","unstructured":"Naelitz, B. D. et al. Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole. Fertil. Steril. 120, 746\u2013754 (2023).","journal-title":"Fertil. Steril."},{"key":"838_CR90","doi-asserted-by":"publisher","unstructured":"Nickel, R. S. et al. Optimising the screening for haemoglobinopathies in pregnancy planning. Hum. Fertil. Camb. Engl. 1\u20136 https:\/\/doi.org\/10.1080\/14647273.2023.2190041 (2023).","DOI":"10.1080\/14647273.2023.2190041"},{"key":"838_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225457","volume":"14","author":"C Satirapod","year":"2019","unstructured":"Satirapod, C. et al. Clinical utility of combined preimplantation genetic testing methods in couples at risk of passing on beta thalassemia\/hemoglobin E disease: a retrospective review from a single center. PLoS One 14, e0225457 (2019).","journal-title":"PLoS One"},{"key":"838_CR92","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bcmd.2013.04.003","volume":"51","author":"A Chaibunruang","year":"2013","unstructured":"Chaibunruang, A. et al. Molecular and hematological studies in a large cohort of \u03b1(0)-thalassemia in northeast Thailand: data from a single referral center. Blood Cells Mol. Dis. 51, 89\u201393 (2013).","journal-title":"Blood Cells Mol. Dis."},{"key":"838_CR93","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.hoc.2022.12.004","volume":"37","author":"A Lal","year":"2023","unstructured":"Lal, A. & Vichinsky, E. The clinical phenotypes of alpha thalassemia. Hematol. Oncol. Clin. North. Am. 37, 327\u2013339 (2023).","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"838_CR94","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/17474124.2018.1496016","volume":"12","author":"S Golfeyz","year":"2018","unstructured":"Golfeyz, S., Lewis, S. & Weisberg, I. S. Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI. Expert. Rev. Gastroenterol. Hepatol. 12, 767\u2013778 (2018).","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"838_CR95","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/jmg.34.4.275","volume":"34","author":"AT Merryweather-Clarke","year":"1997","unstructured":"Merryweather-Clarke, A. T., Pointon, J. J., Shearman, J. D. & Robson, K. J. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34, 275\u2013278 (1997).","journal-title":"J. Med. Genet."},{"key":"838_CR96","doi-asserted-by":"crossref","unstructured":"Pantopoulos, K. Inherited disorders of iron overload. Front. Nutr. 5, (2018).","DOI":"10.3389\/fnut.2018.00103"},{"key":"838_CR97","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.fertnstert.2008.02.129","volume":"91","author":"A Bureti\u0107-Tomljanovi\u0107","year":"2009","unstructured":"Bureti\u0107-Tomljanovi\u0107, A. et al. The impact of hemochromatosis mutations and transferrin genotype on gonadotropin serum levels in infertile men. Fertil. Steril. 91, 1793\u20131800 (2009).","journal-title":"Fertil. Steril."},{"key":"838_CR98","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s11033-008-9372-7","volume":"36","author":"A Gunel-Ozcan","year":"2009","unstructured":"Gunel-Ozcan, A., Basar, M. M., K\u0131sa, U. & Ankaral\u0131, H. C. Hereditary haemochromatosis gene (HFE) H63D mutation shows an association with abnormal sperm motility. Mol. Biol. Rep. 36, 1709\u20131714 (2009).","journal-title":"Mol. Biol. Rep."},{"key":"838_CR99","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.fertnstert.2006.05.034","volume":"86","author":"B Peterlin","year":"2006","unstructured":"Peterlin, B. et al. Analysis of the hemochromatosis mutations C282Y and H63D in infertile men. Fertil. Steril. 86, 1796\u20131798 (2006).","journal-title":"Fertil. Steril."},{"key":"838_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12610-017-0057-8","volume":"27","author":"R El Osta","year":"2017","unstructured":"El Osta, R., Grandpre, N., Monnin, N., Hubert, J. & Koscinski, I. Hypogonadotropic hypogonadism in men with hereditary hemochromatosis. Basic. Clin. Androl. 27, 13 (2017).","journal-title":"Basic. Clin. Androl."},{"key":"838_CR101","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10815-014-0344-7","volume":"32","author":"E Tvrda","year":"2015","unstructured":"Tvrda, E., Peer, R., Sikka, S. C. & Agarwal, A. Iron and copper in male reproduction: a double-edged sword. J. Assist. Reprod. Genet. 32, 3\u201316 (2015).","journal-title":"J. Assist. Reprod. Genet."},{"key":"838_CR102","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1210\/jc.2004-0980","volume":"90","author":"JH McDermott","year":"2005","unstructured":"McDermott, J. H. & Walsh, C. H. Hypogonadism in hereditary hemochromatosis. J. Clin. Endocrinol. Metab. 90, 2451\u20132455 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"838_CR103","first-page":"652","volume":"92","author":"S Oehninger","year":"1998","unstructured":"Oehninger, S., Pike, I. & Slotnick, N. Hemochromatosis and male infertility. Obstet. Gynecol. 92, 652\u2013653 (1998).","journal-title":"Obstet. Gynecol."},{"key":"838_CR104","doi-asserted-by":"publisher","first-page":"1744.e11","DOI":"10.1016\/j.fertnstert.2005.05.070","volume":"84","author":"NG Angelopoulos","year":"2005","unstructured":"Angelopoulos, N. G., Goula, A., Dimitriou, E. & Tolis, G. Reversibility of hypogonadotropic hypogonadism in a patient with the juvenile form of hemochromatosis. Fertil. Steril. 84, 1744.e11\u20131744.e13 (2005).","journal-title":"Fertil. Steril."},{"key":"838_CR105","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms22010021","volume":"22","author":"V Ide","year":"2020","unstructured":"Ide, V., Vanderschueren, D. & Antonio, L. Treatment of men with central hypogonadism: alternatives for testosterone replacement therapy. Int. J. Mol. Sci. 22, 21 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"838_CR106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5045\/br.2022.2022012","volume":"57","author":"P Meerim","year":"2022","unstructured":"Meerim, P. Overview of inherited bone marrow failure syndromes. Blood Res 57, 49\u201354 (2022).","journal-title":"Blood Res"},{"key":"838_CR107","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1182\/blood-2017-05-781799","volume":"130","author":"BP Alter","year":"2017","unstructured":"Alter, B. P. Inherited bone marrow failure syndromes: considerations pre- and posttransplant. Blood 130, 2257\u20132264 (2017).","journal-title":"Blood"},{"key":"838_CR108","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-90-481-9485-8_22","volume":"686","author":"B Gulbis","year":"2010","unstructured":"Gulbis, B. et al. Epidemiology of rare anaemias in Europe. Adv. Exp. Med. Biol. 686, 375\u2013396 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"838_CR109","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mrfmmm.2009.01.013","volume":"668","author":"AD Auerbach","year":"2009","unstructured":"Auerbach, A. D. Fanconi anemia and its diagnosis. Mutat. Res. 668, 4\u201310 (2009).","journal-title":"Mutat. Res."},{"key":"838_CR110","doi-asserted-by":"publisher","first-page":"100589","DOI":"10.1016\/j.blre.2019.100589","volume":"37","author":"MO Fiesco-Roa","year":"2019","unstructured":"Fiesco-Roa, M. O., Giri, N., McReynolds, L. J., Best, A. F. & Alter, B. P. Genotype-phenotype associations in Fanconi anemia: a literature review. Blood Rev. 37, 100589 (2019).","journal-title":"Blood Rev."},{"key":"838_CR111","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tig.2018.12.007","volume":"35","author":"V Tsui","year":"2019","unstructured":"Tsui, V. & Crismani, W. The Fanconi anemia pathway and fertility. Trends Genet 35, 199\u2013214 (2019).","journal-title":"Trends Genet"},{"key":"838_CR112","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0002-9343(91)90197-6","volume":"91","author":"JM Liu","year":"1991","unstructured":"Liu, J. M., Auerbach, A. D. & Young, N. S. Fanconi anemia presenting unexpectedly in an adult kindred with no dysmorphic features. Am. J. Med. 91, 555\u2013557 (1991).","journal-title":"Am. J. Med."},{"key":"838_CR113","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/10409238.2019.1568963","volume":"54","author":"J Basbous","year":"2019","unstructured":"Basbous, J. & Constantinou, A. A tumor suppressive DNA translocase named FANCM. Crit. Rev. Biochem. Mol. Biol. 54, 27\u201340 (2019).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"838_CR114","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ajhg.2018.07.005","volume":"103","author":"L Kasak","year":"2018","unstructured":"Kasak, L. et al. Bi-allelic recessive loss-of-function variants in FANCM cause non-obstructive azoospermia. Am. J. Hum. Genet. 103, 200\u2013212 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"838_CR115","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41436-018-0015-7","volume":"21","author":"H Yin","year":"2019","unstructured":"Yin, H. et al. A homozygous FANCM frameshift pathogenic variant causes male infertility. Genet. Med. 21, 62\u201370 (2019).","journal-title":"Genet. Med."},{"key":"838_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004471","volume":"10","author":"Y Luo","year":"2014","unstructured":"Luo, Y. et al. Hypersensitivity of primordial germ cells to compromised replication-associated DNA repair involves ATM-p53-p21 signaling. PLOS Genet. 10, e1004471 (2014).","journal-title":"PLOS Genet."},{"key":"838_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159800","volume":"11","author":"C Fu","year":"2016","unstructured":"Fu, C., Begum, K., Jordan, P. W., He, Y. & Overbeek, P. A. Dearth and delayed maturation of testicular germ cells in Fanconi anemia E mutant male mice. PLoS One 11, e0159800 (2016).","journal-title":"PLoS One"},{"key":"838_CR118","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1182\/blood-2006-07-036657","volume":"109","author":"JE Wagner","year":"2007","unstructured":"Wagner, J. E. et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 109, 2256\u20132262 (2007).","journal-title":"Blood"},{"key":"838_CR119","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/pbc.25078","volume":"61","author":"JP Ginsberg","year":"2014","unstructured":"Ginsberg, J. P. et al. Testicular tissue cryopreservation in prepubertal male children: an analysis of parental decision-making. Pediatr. Blood Cancer 61, 1673\u20131678 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"838_CR120","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/08880018.2015.1129567","volume":"33","author":"L Paustian","year":"2016","unstructured":"Paustian, L. et al. Androgen therapy in Fanconi anemia: a retrospective analysis of 30 years in Germany. Pediatr. Hematol. Oncol. 33, 5\u201312 (2016).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"838_CR121","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.stemcr.2014.10.014","volume":"4","author":"Q-S Zhang","year":"2014","unstructured":"Zhang, Q.-S. et al. Oxymetholone therapy of Fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling. Stem Cell Rep. 4, 90\u2013102 (2014).","journal-title":"Stem Cell Rep."},{"key":"838_CR122","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1182\/blood.V128.22.5075.5075","volume":"128","author":"LL Ribeiro","year":"2016","unstructured":"Ribeiro, L. L. et al. Excellent option therapy of BONE marrow failure in Fanconi anemia patients without full match donor. Blood 128, 5075 (2016).","journal-title":"Blood"},{"key":"838_CR123","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1001\/jama.285.24.3130","volume":"285","author":"Y Verlinsky","year":"2001","unstructured":"Verlinsky, Y., Rechitsky, S., Schoolcraft, W., Strom, C. & Kuliev, A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 285, 3130\u20133133 (2001).","journal-title":"JAMA"},{"key":"838_CR124","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","volume":"321","author":"E Gluckman","year":"1989","unstructured":"Gluckman, E. et al. Hematopoietic reconstitution in a patient with Fanconi\u2019s anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174\u20131178 (1989).","journal-title":"N. Engl. J. Med."},{"key":"838_CR125","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.hoc.2009.01.004","volume":"23","author":"JM Lipton","year":"2009","unstructured":"Lipton, J. M. & Ellis, S. R. Diamond Blackfan anemia: diagnosis, treatment and molecular pathogenesis. Hematol. Oncol. Clin. North. Am. 23, 261\u2013282 (2009).","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"838_CR126","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1365-2141.2008.07269.x","volume":"142","author":"A Vlachos","year":"2008","unstructured":"Vlachos, A. et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br. J. Haematol. 142, 859\u2013876 (2008).","journal-title":"Br. J. Haematol."},{"key":"838_CR127","doi-asserted-by":"crossref","unstructured":"Piantanida, N. et al. Deficiency of ribosomal protein S26, which is mutated in a subset of patients with Diamond Blackfan anemia, impairs erythroid differentiation. Front. Genet. 13, (2022).","DOI":"10.3389\/fgene.2022.1045236"},{"key":"838_CR128","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1182\/blood-2004-03-1016","volume":"105","author":"Y Ohene-Abuakwa","year":"2005","unstructured":"Ohene-Abuakwa, Y., Orfali, K. A., Marius, C. & Ball, S. E. Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect. Blood 105, 838\u2013846 (2005).","journal-title":"Blood"},{"key":"838_CR129","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1182\/hematology.2021000314","volume":"2021","author":"LM Da Costa","year":"2021","unstructured":"Da Costa, L. M., Marie, I. & Leblanc, T. M. Diamond-Blackfan anemia. Hematol. Am. Soc. Hematol. Educ. Program. 2021, 353\u2013360 (2021).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"838_CR130","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.seminhematol.2011.01.004","volume":"48","author":"A Narla","year":"2011","unstructured":"Narla, A., Vlachos, A. & Nathan, D. G. Diamond Blackfan anemia treatment: past, present, and future. Semin. Hematol. 48, 117\u2013123 (2011).","journal-title":"Semin. Hematol."},{"key":"838_CR131","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/bjh.18393","volume":"199","author":"P Quarello","year":"2022","unstructured":"Quarello, P., Ramenghi, U. & Fagioli, F. Diamond-Blackfan anaemia with iron overload: a serious issue. Br. J. Haematol. 199, 171\u2013172 (2022).","journal-title":"Br. J. Haematol."},{"key":"838_CR132","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/andr.13319","volume":"11","author":"SR S\u00e1nchez Gonz\u00e1lez","year":"2023","unstructured":"S\u00e1nchez Gonz\u00e1lez, S. R. et al. Cortisol modulates Ca2+ signaling and acrosome reaction in human sperm. Andrology 11, 134\u2013142 (2023).","journal-title":"Andrology"},{"key":"838_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12610-016-0029-4","volume":"26","author":"R El Osta","year":"2016","unstructured":"El Osta, R. et al. Anabolic steroids abuse and male infertility. Basic. Clin. Androl. 26, 2 (2016).","journal-title":"Basic. Clin. Androl."},{"key":"838_CR134","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.33549\/physiolres.934508","volume":"69","author":"R HAMPL","year":"2020","unstructured":"HAMPL, R. & ST\u00c1RKA, L. Glucocorticoids affect male testicular steroidogenesis. Physiol. Res. 69, S205\u2013S210 (2020).","journal-title":"Physiol. Res."},{"key":"838_CR135","first-page":"109","volume":"35","author":"S Whirledge","year":"2010","unstructured":"Whirledge, S. & Cidlowski, J. A. Glucocorticoids, stress, and fertility. Minerva Endocrinol. 35, 109\u2013125 (2010).","journal-title":"Minerva Endocrinol."},{"key":"838_CR136","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/10253890.2011.585188","volume":"15","author":"Y Chen","year":"2012","unstructured":"Chen, Y., Wang, Q., Wang, F.-F., Gao, H.-B. & Zhang, P. Stress induces glucocorticoid-mediated apoptosis of rat Leydig cells in vivo. Stress 15, 74\u201384 (2012).","journal-title":"Stress"},{"key":"838_CR137","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/humrep\/15.9.1917","volume":"15","author":"H Yazawa","year":"2000","unstructured":"Yazawa, H., Sasagawa, I. & Nakada, T. Apoptosis of testicular germ cells induced by exogenous glucocorticoid in rats. Hum. Reprod. 15, 1917\u20131920 (2000).","journal-title":"Hum. Reprod."},{"key":"838_CR138","first-page":"128","volume":"11","author":"A Remacha","year":"2013","unstructured":"Remacha, A. et al. Guidelines on haemovigilance of post-transfusional iron overload. Blood Transfus. 11, 128\u2013139 (2013).","journal-title":"Blood Transfus."},{"key":"838_CR139","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1196\/annals.1345.028","volume":"1054","author":"A Kuliev","year":"2005","unstructured":"Kuliev, A., Rechitsky, S., Tur-Kaspa, I. & Verlinsky, Y. Preimplantation genetics: improving access to stem cell therapy. Ann. N. Y. Acad. Sci. 1054, 223\u2013227 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"838_CR140","first-page":"803","volume":"292","author":"JE Wagner","year":"2004","unstructured":"Wagner, J. E., Kahn, J. P., Wolf, S. M. & Lipton, J. M. Preimplantation testing to produce an HLA-matched donor infant. JAMA 292, 803\u2013804 (2004).","journal-title":"JAMA"},{"key":"838_CR141","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jpeds.2020.04.027","volume":"223","author":"M Attia","year":"2020","unstructured":"Attia, M., Kripalani, S., Darbari, I. & Nickel, R. S. Parents of children with sickle cell disease are interested in preimplantation genetic testing. J. Pediatr. 223, 178\u2013182.e2 (2020).","journal-title":"J. Pediatr."},{"key":"838_CR142","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S1368980000000173","volume":"3","author":"SM Fishman","year":"2000","unstructured":"Fishman, S. M., Christian, P. & West, K. P. The role of vitamins in the prevention and control of anaemia. Public. Health Nutr. 3, 125\u2013150 (2000).","journal-title":"Public. Health Nutr."},{"key":"838_CR143","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.nutr.24.012003.132306","volume":"24","author":"MJ Koury","year":"2004","unstructured":"Koury, M. J. & Ponka, P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu. Rev. Nutr. 24, 105\u2013131 (2004).","journal-title":"Annu. Rev. Nutr."},{"key":"838_CR144","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3904\/kjim.2016.421","volume":"33","author":"NH Kim","year":"2018","unstructured":"Kim, N. H. et al. Should asymptomatic young men with iron deficiency anemia necessarily undergo endoscopy? Korean J. Intern. Med. 33, 1084\u20131092 (2018).","journal-title":"Korean J. Intern. Med."},{"key":"838_CR145","first-page":"671","volume":"75","author":"S Killip","year":"2007","unstructured":"Killip, S., Bennett, J. M. & Chambers, M. D. Iron deficiency anemia. Am. Fam. Physician 75, 671\u2013678 (2007).","journal-title":"Am. Fam. Physician"},{"key":"838_CR146","first-page":"73","volume":"113","author":"A Zanella","year":"1989","unstructured":"Zanella, A. et al. Sensitivity and predictive value of serum ferritin and free erythrocyte protoporphyrin for iron deficiency. J. Lab. Clin. Med. 113, 73\u201378 (1989).","journal-title":"J. Lab. Clin. Med."},{"key":"838_CR147","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","volume":"1800","author":"W Wang","year":"2010","unstructured":"Wang, W., Knovich, M. A., Coffman, L. G., Torti, F. M. & Torti, S. V. Serum ferritin: past, present and future. Biochim. Biophys. Acta 1800, 760\u2013769 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"838_CR148","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1756283X11398736","volume":"4","author":"TD Johnson-Wimbley","year":"2011","unstructured":"Johnson-Wimbley, T. D. & Graham, D. Y. Diagnosis and management of iron deficiency anemia in the 21st century. Ther. Adv. Gastroenterol. 4, 177\u2013184 (2011).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"838_CR149","doi-asserted-by":"publisher","first-page":"929285","DOI":"10.1155\/2012\/929285","volume":"2012","author":"JG Reyes","year":"2012","unstructured":"Reyes, J. G. et al. The hypoxic testicle: physiology and pathophysiology. Oxid. Med. Cell. Longev. 2012, 929285 (2012).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"838_CR150","doi-asserted-by":"publisher","first-page":"725933","DOI":"10.3389\/fcell.2021.725933","volume":"9","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Effects of environmental and pathological hypoxia on male fertility. Front. Cell Dev. Biol. 9, 725933 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"838_CR151","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1677\/joe.0.1030059","volume":"103","author":"JR Gosney","year":"1984","unstructured":"Gosney, J. R. Effects of hypobaric hypoxia on the Leydig cell population of the testis of the rat. J. Endocrinol. 103, 59\u201362 (1984).","journal-title":"J. Endocrinol."},{"key":"838_CR152","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF01208490","volume":"38","author":"DK Saxena","year":"1995","unstructured":"Saxena, D. K. Effect of hypoxia by intermittent altitude exposure on semen characteristics and testicular morphology of male rhesus monkeys. Int. J. Biometeorol. 38, 137\u2013140 (1995).","journal-title":"Int. J. Biometeorol."},{"key":"838_CR153","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/jrf.0.0160055","volume":"16","author":"J Donayre","year":"1968","unstructured":"Donayre, J., Guerra-Garc\u00eda, R., Moncloa, F. & Sobrevilla, L. A. Endocrine studies at high altitude. IV. Changes in the semen of men. J. Reprod. Fertil. 16, 55\u201358 (1968).","journal-title":"J. Reprod. Fertil."},{"key":"838_CR154","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1745-7262.2008.00346.x","volume":"10","author":"V Verratti","year":"2008","unstructured":"Verratti, V. et al. Evidence that chronic hypoxia causes reversible impairment on male fertility. Asian J. Androl. 10, 602\u2013606 (2008).","journal-title":"Asian J. Androl."},{"key":"838_CR155","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/2230-8210.131158","volume":"18","author":"A Soliman","year":"2014","unstructured":"Soliman, A., Yassin, M. & De Sanctis, V. Intravenous iron replacement therapy in eugonadal males with iron-deficiency anemia: effects on pituitary gonadal axis and sperm parameters; a pilot study. Indian. J. Endocrinol. Metab. 18, 310\u2013316 (2014).","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"838_CR156","first-page":"11","volume":"66","author":"S Mehta","year":"2018","unstructured":"Mehta, S. et al. Assessment of pituitary gonadal axis and sperm parameters in anemic eugonadal males before and after correction of iron deficiency anemia. J. Assoc. Physicians India 66, 11\u201312 (2018).","journal-title":"J. Assoc. Physicians India"},{"key":"838_CR157","first-page":"27","volume":"5","author":"AA Nikolaev","year":"1998","unstructured":"Nikolaev, A. A., Lutski\u012d, D. L., Nikolaeva, N. N. & Lozhkina, L. V. [Iron and nonheme iron protein metabolism in ejaculates with varying degrees of fertility]. Urol. Nefrol. 5, 27\u201331 (1998).","journal-title":"Urol. Nefrol."},{"key":"838_CR158","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3390\/nu14102063","volume":"14","author":"C-W Tsao","year":"2022","unstructured":"Tsao, C.-W., Liao, Y.-R., Chang, T.-C., Liew, Y.-F. & Liu, C.-Y. Effects of iron supplementation on testicular function and spermatogenesis of iron-deficient rats. Nutrients 14, 2063 (2022).","journal-title":"Nutrients"},{"key":"838_CR159","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/JU.0000000000001521","volume":"205","author":"PN Schlegel","year":"2021","unstructured":"Schlegel, P. N. et al. Diagnosis and treatment of infertility in men: AUA\/ASRM guideline part I. J. Urol. 205, 36\u201343 (2021).","journal-title":"J. Urol."},{"key":"838_CR160","first-page":"98","volume":"87","author":"MW Short","year":"2013","unstructured":"Short, M. W. & Domagalski, J. E. Iron deficiency anemia: evaluation and management. Am. Fam. Physician 87, 98\u2013104 (2013).","journal-title":"Am. Fam. Physician"},{"key":"838_CR161","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3945\/an.115.012021","volume":"7","author":"S Venkatramanan","year":"2016","unstructured":"Venkatramanan, S., Armata, I. E., Strupp, B. J. & Finkelstein, J. L. Vitamin B-12 and cognition in children. Adv. Nutr. Bethesda Md. 7, 879\u2013888 (2016).","journal-title":"Adv. Nutr. Bethesda Md."},{"key":"838_CR162","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fnut.2020.00101","volume":"7","author":"A Melse-Boonstra","year":"2020","unstructured":"Melse-Boonstra, A. Bioavailability of micronutrients from nutrient-dense whole foods: zooming in on dairy, vegetables, and fruits. Front. Nutr. 7, 101 (2020).","journal-title":"Front. Nutr."},{"key":"838_CR163","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1182\/blood-2018-99-111607","volume":"132","author":"K Diaz","year":"2018","unstructured":"Diaz, K. et al. Prevalence of folic acid deficiency and cost effectiveness of folic acid testing: a single center experience. Blood 132, 4878 (2018).","journal-title":"Blood"},{"key":"838_CR164","doi-asserted-by":"publisher","first-page":"145","DOI":"10.7861\/clinmedicine.15-2-145","volume":"15","author":"MJ Shipton","year":"2015","unstructured":"Shipton, M. J. & Thachil, J. Vitamin B12 deficiency \u2014 a 21st century perspective. Clin. Med. 15, 145\u2013150 (2015).","journal-title":"Clin. Med."},{"key":"838_CR165","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1753-4887.2004.tb00070.x","volume":"62","author":"PJ Stover","year":"2004","unstructured":"Stover, P. J. Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 62, S3\u2013S12 (2004).","journal-title":"Nutr. Rev."},{"key":"838_CR166","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jgf2.31","volume":"18","author":"T Nagao","year":"2017","unstructured":"Nagao, T. & Hirokawa, M. Diagnosis and treatment of macrocytic anemias in adults. J. Gen. Fam. Med. 18, 200\u2013204 (2017).","journal-title":"J. Gen. Fam. Med."},{"key":"838_CR167","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/hmg\/10.7.687","volume":"10","author":"SB Baylin","year":"2001","unstructured":"Baylin, S. B. et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10, 687\u2013692 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"838_CR168","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/S0007114519002526","volume":"123","author":"J Steluti","year":"2020","unstructured":"Steluti, J., Palchetti, C. Z., Miranda, A. M., Fisberg, R. M. & Marchioni, D. M. DNA methylation and one-carbon metabolism related nutrients and polymorphisms: analysis after mandatory flour fortification with folic acid. Br. J. Nutr. 123, 23\u201329 (2020).","journal-title":"Br. J. Nutr."},{"key":"838_CR169","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.fertnstert.2008.06.010","volume":"92","author":"JC Boxmeer","year":"2009","unstructured":"Boxmeer, J. C. et al. Low folate in seminal plasma is associated with increased sperm DNA damage. Fertil. Steril. 92, 548\u2013556 (2009).","journal-title":"Fertil. Steril."},{"key":"838_CR170","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/jcmm.17119","volume":"26","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Studying the mechanism of sperm DNA damage caused by folate deficiency. J. Cell. Mol. Med. 26, 776\u2013788 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"838_CR171","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0015-0282(01)03229-0","volume":"77","author":"WY Wong","year":"2002","unstructured":"Wong, W. Y. et al. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil. Steril. 77, 491\u2013498 (2002).","journal-title":"Fertil. Steril."},{"key":"838_CR172","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/biom7020042","volume":"7","author":"SA Banihani","year":"2017","unstructured":"Banihani, S. A. Vitamin B12 and semen quality. Biomolecules 7, 42 (2017).","journal-title":"Biomolecules"},{"key":"838_CR173","doi-asserted-by":"publisher","first-page":"100356","DOI":"10.1016\/j.esxm.2021.100356","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Zhang, W., Dai, Y., Jiang, H. & Zhang, X. Serum folic acid and erectile dysfunction: a systematic review and meta-analysis. Sex. Med. 9, 100356 (2021).","journal-title":"Sex. Med."},{"key":"838_CR174","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/bjh.14393","volume":"180","author":"A Ekong","year":"2018","unstructured":"Ekong, A., Berg, L., Amos, R. J. & Tsitsikas, D. A. Regular automated red cell exchange transfusion in the management of stuttering priapism complicating sickle cell disease. Br. J. Haematol. 180, 585\u2013588 (2018).","journal-title":"Br. J. Haematol."},{"key":"838_CR175","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/aja.2011.114","volume":"14","author":"HR Levey","year":"2012","unstructured":"Levey, H. R., Kutlu, O. & Bivalacqua, T. J. Medical management of ischemic stuttering priapism: a contemporary review of the literature. Asian J. Androl. 14, 156\u2013163 (2012).","journal-title":"Asian J. Androl."},{"key":"838_CR176","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/JU.0000000000002767","volume":"208","author":"TJ Bivalacqua","year":"2022","unstructured":"Bivalacqua, T. J. et al. The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA\/SMSNA guideline. J. Urol. 208, 43\u201352 (2022).","journal-title":"J. Urol."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00838-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T08:34:20Z","timestamp":1730968460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00838-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":176,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1038\/s41585-023-00838-8","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"10 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.V.P. is a speaker for Halozyme Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}